They Buried What Ivermectin Actually Does to Viruses | Dr. Alexis Cowan
Link to full episode: https://www.youtube.com/watch?v=WNXknj4EL1w
Ivermectin kept showing up as a hit, and almost nobody was allowed to say so. Dr. Alexis Cowan explains that when labs ran in vitro screens looking for small molecules that could stop the spike protein from entering cells, ivermectin and ivermectin-like molecules popped out repeatedly, across multiple labs. A colleague of hers worked on that screening. The data pointing toward antiviral activity was not pushed toward the public, and Cowan’s read is blunt: it was completely ignored, for reasons nobody wanted to explain.
Cowan is a metabolic researcher, so she walks Danny through the pharmacology instead of the politics. Ivermectin is a Nobel Prize winning, off-patent drug that should cost almost nothing. Its safety profile is enormous, tolerated at doses far beyond the normal range with minimal side effects. Yet doctors were afraid to prescribe it because they believed their licenses were on the line. The studies that did get run used timing and dosing so erratic that no clean conclusion was possible. Danny brings the other side too, from Professor Dave’s debate with Pierre Kory: no trial ever proved ivermectin did anything for COVID, and a group of doctors turned the drug into a marked-up subscription business that only worked because ordinary patients could not get a prescription anywhere else.
Then there is Mary Talley Bowden, who prescribed it to large numbers of patients, said she saw real results, made no extra money doing it, and was thrown out of her hospital and treated as an outcast. Cowan describes one of Bowden’s patients with severe histamine reactions after the shot who improved on ivermectin. Cowan has her own case as well: her partner and stepson both had COVID while she happened to be taking ivermectin for a stomach bug, and she never got sick. She also points to its effect on the gut, raising bifidobacteria and hitting pathogens without wiping out beneficial bacteria.
The bigger question is why the pressure came so fast and so hard, from agencies and from the largest companies, including the fight to block monoclonal antibodies while people sat in stadium parking lots for half a day waiting for them. Cowan will not call it a plan. She will say it is hard not to read some of it as nefarious.
Subscribe to this channel: https://www.youtube.com/channel/UCQ_piSR8gm-TfHZcDWOJciA?sub_confirmation=1
Comments
Latest news
@DannyJonesClips
August 8, 2026 at 6:51 am
Link to full episode: https://www.youtube.com/watch?v=WNXknj4EL1w
@strongbelieveroftheholybible
August 8, 2026 at 6:51 am
Pharmakeia means sorcery
Revelation 18:23 For by thy sorceries were all nations deceived.
@whitey792000
August 8, 2026 at 6:51 am
🚨 Cancer is Parasites 1891 Boston Medical… 99% of pharmaceuticals are made with crude oil 🛢 and Rockefellers hid these truths…👹🔥 there is no money in Curing people…🎉🎉
@SamSam-jn2rw
August 8, 2026 at 6:51 am
Do better Dan, you can get better guests not cracking out
@lamont814
August 8, 2026 at 6:51 am
More than 3.7 billion doses of ivermectin have been safely administered to humans globally since human distribution began in 1987. On the contrary, Fauci and the FDA pushed the administration of toxic remdesivir on critically ill elderly patients. The deadly combination of remdesivir and ventilators ensured most never recovered from the treatment.
Remdesivir carries numerous documented clinical warnings that must be carefully managed by medical providers. Because it is administered via an intravenous (IV) infusion, patients are monitored closely during and after the procedure.
The primary known dangers and adverse reactions outlined by the FDA and medical health systems include:
1. Liver Toxicity and Elevated Transaminases
* Enzyme Spikes: A very common side effect of remdesivir is an increase in liver enzymes (specifically transaminases like ALT and AST)
* Liver Injury Risk: High enzyme levels can indicate inflammation or damage to cells in the liver. Doctors are required to perform hepatic laboratory testing before starting the drug and throughout the treatment course.
* Discontinuation: If a patient's ALT levels increase to more than 10 times the upper limit of normal, or if they show signs of active liver inflammation, the drug must be stopped.
2. Severe Allergic and Infusion Reactions
* Anaphylaxis: Remdesivir can cause serious, life-threatening allergic reactions and anaphylaxis during or immediately following the IV infusion.
* Infusion Symptoms: Severe infusion-related symptoms include dangerous drops in blood pressure (hypotension), abnormally fast or slow heart rates, wheezing, shortness of breath, facial/throat swelling (angioedema), severe shivering, and rash.
* Prevention: Medical staff often utilize slower infusion rates (up to 120 minutes) to mitigate these risks and must observe the patient for at least one hour post-infusion.
3. Renal (Kidney) Impairment Concerns
* Accumulation Risk: Remdesivir is primarily cleared by the kidneys. In patients with severe preexisting kidney disease or renal failure, the drug or its compounding vehicles—such as the excipient SBECD—can accumulate, potentially resulting in localized kidney or liver toxicity.
* Monitoring: While updated clinical guidelines have expanded safe use in various stages of renal function under strict medical supervision, healthcare providers still mandate baseline blood and urine tests to assess a patient's glomerular filtration rate (eGFR) before administering the drug.
4. Common and Minor Side Effects
* Gastrointestinal Distress: Nausea is documented as the single most common, mild adverse effect experienced by patients undergoing the treatment regimen.
* General Fatigue: Mild to moderate headaches and temporary fatigue are regularly noted during the 3-to-5-day infusion course.
@cantseemtogetright
August 8, 2026 at 6:51 am
Ivermectin is completely ineffective at treating COVID. Stop platforming people who spread these false narratives.
@rollerskatertexasgirl
August 8, 2026 at 6:51 am
Thank you 🎉